Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
23.4%
% of CNCR's 64 holdings also in IDNA
32.6%
% of IDNA's 51 holdings also in CNCR
Overlap by Weight
Sector Drift (CNCR minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CNCR |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
BIONTECH SE SPONSORED ADR | 1.8% | 4.2% | 1.8% |
 |
EXELIXIS INC | 1.8% | 5.2% | 1.8% |
|
JANUX THERAPEUTICS, INC. | 1.7% | 2.4% | 1.7% |
|
REVOLUTION MEDICINES, INC. | 1.7% | 4.0% | 1.7% |
|
ARCELLX, INC. | 1.5% | 3.8% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
CNCR Overweight Relative to IDNA
|
SUMMIT THERAPEUTICS INC | 2.2% |
|
FATE THERAPEUTICS INC | 2.1% |
|
SCHRODINGER, INC. | 2.0% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | 1.8% |
|
2SEVENTY BIO, INC. | 1.8% |
|
ARVINAS, INC. | 1.8% |
|
Y-MABS THERAPEUTICS, INC. | 1.8% |
 |
GENMAB A/S SPONSORED ADR | 1.7% |
 |
IMMUNOCORE HOLDINGS PLC SPONSORED AD | 1.7% |
|
NUVATION BIO INC CLASS A | 1.7% |
CNCR Underweight Relative to IDNA
 |
BEIGENE, LTD. | -5.8% |
 |
ROCHE HOLDING LTD | -5.5% |
 |
SANOFI-AVENTIS | -5.5% |
|
GSK PLC | -5.3% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -5.2% |
|
ASTRAZENECA PLC | -5.1% |
|
GENMAB A/S | -4.6% |
|
INCYTE CORP | -4.0% |
|
TWIST BIOSCIENCE CORP. | -3.6% |
|
EXELIXIS INC | -3.5% |